Early Effects of Abaloparatide on Tissue-Based Indices of Bone Formation and Resorption
Status:
Completed
Trial end date:
2020-07-15
Target enrollment:
Participant gender:
Summary
The objective of this study is to measure the early effects of abaloparatide on tissue-based
bone formation using samples obtained by transiliac crest bone biopsy after quadruple
fluorochrome labeling.